BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Clinical trials for BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM trials appear
Sign up with your email to follow new studies for BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Selective immune cell removal may tame transplant complications
Disease control CompletedThis study tested whether removing a specific type of immune cell (naïve T cells) from donor stem cell grafts could prevent graft-versus-host disease (GVHD) after a stem cell transplant for blood cancers. The trial enrolled 84 patients who received high- or medium-intensity chemo…
Matched conditions: BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
New hope for rare blood cancer: targeted drug shows promise in early trial
Disease control CompletedThis early-phase study tested the drug venetoclax in 5 adults with a rare and aggressive blood cancer called BPDCN. The goal was to see if the drug is safe and can shrink tumors. Participants had already tried other treatments. The study looked at side effects and how well the ca…
Matched conditions: BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC